Loading patent…
OwnerVishagan Vanangamudi Sulur, Vanangamudi Subramaniam Sulur +1inventors
InventorsVishagan Vanangamudi Sulur, Vanangamudi Subramaniam Sulur, Ramanathan Narayanan Lakshmi
Estimating the term…
Provided herein are compositions for topical application to a subject, for treating epidermolysis bullosa (EB). Also disclosed are methods for treating skin in a person suffering from EB. The methods comprise providing a composition comprising fusidic acid and one or more pharmaceutically acceptable excipients; and topically applying, or instructing to topically apply, the composition to skin of a person suffering from EB. In some embodiments, the composition is topically administered to treat a non-healing wound, chronic wound or lesional skin in a patient suffering from EB, to reduce the likelihood of skin infections, to reduce the likelihood of scar formation, to prevent or reduce the risk of a skin blister from becoming infected, to treat intact blisters on skin, to treat skin dysbiosis, to alter bacterial diversity of the skin microbiome, or to increase the quality of life in a subject suffering from EB.
A composition, comprising:
A composition, comprising:
A method for treating skin in a person suffering from epidermolysis bullosa (EB), comprising:
A method for treating a non-healing wound, a chronic wound or lesional skin in a person suffering from EB, comprising:
A method for reducing likelihood of skin infection in a person suffering from EB, comprising:
A method for (i) treating skin dysbiosis or (ii) altering bacterial diversity of skin microbiome, comprising:
A method for improving quality of life in a subject suffering from EB, comprising:
A method for reducing likelihood of scar formation in skin of in a person suffering from epidermolysis bullosa (EB), comprising:
A method for preventing or reducing risk of a skin blister from becoming infected or for treating intact blisters on skin of a person suffering from EB, comprising:
Dependencies are inferred from the claim text.